| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |